Correlation Between Kaufman Broad and Vertex Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Kaufman Broad and Vertex Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kaufman Broad and Vertex Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Kaufman Broad SA and Vertex Pharmaceuticals Incorporated, you can compare the effects of market volatilities on Kaufman Broad and Vertex Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kaufman Broad with a short position of Vertex Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kaufman Broad and Vertex Pharmaceuticals.

Diversification Opportunities for Kaufman Broad and Vertex Pharmaceuticals

-0.42

Correlation Coefficient

Kaufman Broad  Vertex Pharmaceuticals

Very good diversification

The 3 months correlation between Kaufman and Vertex is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Kaufman Broad SA and Vertex Pharmaceuticals Incorpo in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vertex Pharmaceuticals and Kaufman Broad is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kaufman Broad SA are associated (or correlated) with Vertex Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vertex Pharmaceuticals has no effect on the direction of Kaufman Broad i.e., Kaufman Broad and Vertex Pharmaceuticals go up and down completely randomly.

Pair Corralation between Kaufman Broad and Vertex Pharmaceuticals

Assuming the 90 days horizon Kaufman Broad SA is expected to generate 0.76 times more return on investment than Vertex Pharmaceuticals. However, Kaufman Broad SA is 1.32 times less risky than Vertex Pharmaceuticals. It trades about 0.02 of its potential returns per unit of risk. Vertex Pharmaceuticals Incorporated is currently generating about -0.02 per unit of risk. If you would invest  3,086  in Kaufman Broad SA on April 19, 2025 and sell it today you would earn a total of  29.00  from holding Kaufman Broad SA or generate 0.94% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Kaufman Broad SA  vs.  Vertex Pharmaceuticals Incorpo

Kaufman Broad SA

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Kaufman Broad SA are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, Kaufman Broad is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Vertex Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Vertex Pharmaceuticals Incorporated has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Vertex Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Kaufman Broad and Vertex Pharmaceuticals

The main advantage of trading using opposite Kaufman Broad and Vertex Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kaufman Broad position performs unexpectedly, Vertex Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vertex Pharmaceuticals will offset losses from the drop in Vertex Pharmaceuticals' long position.

The idea behind Kaufman Broad SA and Vertex Pharmaceuticals Incorporated pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.